What is BioLife Solutions?
BioLife Solutions operates at the intersection of biotechnology and industrial bioprocessing, providing a comprehensive suite of tools designed to protect living cells. The company's portfolio includes proprietary biopreservation media, closed-system processing hardware, and advanced cryogenic storage solutions. By addressing the inherent fragility of biological materials, BioLife Solutions enables researchers and commercial manufacturers to maintain therapeutic integrity throughout the entire supply chain. Their market position is defined by a commitment to regulatory compliance and technical precision, which are vital for the successful commercialization of next-generation therapies in the rapidly evolving field of regenerative medicine.
How much funding has BioLife Solutions raised?
BioLife Solutions has raised a total of $15.4M across 1 funding round:
Stock Offering
$15.4M
Stock Issuance/Offering (2014): $15.4M, investors not publicly disclosed
Key Investors in BioLife Solutions
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for BioLife Solutions?
With the support of its recent major strategic investment, BioLife Solutions is well-positioned to accelerate its operational scaling and expand its footprint in the global bioprocessing market. The company is expected to leverage this capital to enhance its manufacturing capabilities and further integrate its closed-system technologies into clinical workflows. As the demand for standardized, high-quality cell and gene therapy production continues to rise, BioLife Solutions will likely focus on deepening its regulatory support services and expanding its cryogenic transport infrastructure. This strategic roadmap aims to solidify the company's role as a foundational pillar in the future of personalized medicine and advanced therapeutic delivery.
See full BioLife Solutions company page
